Biomarker for Patients With Fabry Disease (BioFabry)
NCT02778295 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new mass spectrography-based biomarker for the early and sensitive diagnosis of Fabry disease from the blood
Conditions
- Angiokeratomas
- Chronic Kidney Disease
- Ocular Abnormalities
- Hearing Loss
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
NCT06007768 ·Status: COMPLETED
-
Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging
NCT06568783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neuropathic Pain and Fabry Disease
NCT00168974 ·Status: COMPLETED
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Defining the Basis of Fibromuscular Dysplasia (FMD)
NCT01967511 ·Status: RECRUITING
-
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)
NCT02654340 ·Status: TERMINATED
-
Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.
NCT02926963 ·Status: TERMINATED ·Phase: NA
-
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
NCT02777775 ·Status: COMPLETED
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Investigation of Biomarkers in Susac Syndrome
NCT01273792 ·Status: UNKNOWN
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
NCT02680431 ·Status: UNKNOWN
-
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02422407 ·Status: COMPLETED
-
Stromal Gene Expression During Pulmonary Sarcoidosis
NCT00837668 ·Status: TERMINATED
-
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 ·Status: TERMINATED
-
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 ·Status: UNKNOWN
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Gene First Approach to Connective Tissue Disease
NCT04664478 ·Status: COMPLETED
-
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
NCT01778569 ·Status: COMPLETED
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED